Financial Performance - For the years ended November 30, 2023 and 2022, the Company reported net income of 113,541, respectively[74]. - As of November 30, 2023, the Company had 134,421[72]. - The Sponsor funded extension payments totaling 68.4 million held in the Trust Account[65]. Business Operations - As of November 30, 2023, the Company had not commenced any operations and generated no operating revenues prior to its initial Business Combination[58]. - The Company amended its Trust Agreement to extend the deadline for completing a business combination to February 3, 2024[66]. - The company reported no off-balance sheet arrangements as of November 30, 2023[82]. Initial Public Offering - The Initial Public Offering raised approximately 1.9 million available for operating expenses[61]. - The total consideration for the Merger was 10.00 each[70]. - The company paid a cash underwriting discount of 1,725,000[79]. - The underwriters are entitled to a deferred fee of 3,018,750, payable only upon completion of a Business Combination[79]. Regulatory and Compliance - The company qualifies as an "emerging growth company" and is exempt from certain reporting requirements applicable to other public companies[84]. - The company has elected not to opt out of the extended transition period for new or revised financial accounting standards, allowing it to adopt standards at the same time as private companies[85]. Economic Impact - The company does not believe inflation had a material impact on its business, revenues, or operating results during the reported period[82].
Alset Capital Acquisition (ACAX) - 2023 Q4 - Annual Report